These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37450030)
1. Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma. Jia W; Shi W; Yao Q; Mao Z; Chen C; Fan A; Wang Y; Zhao Z; Li J; Song W J Cancer Res Clin Oncol; 2023 Nov; 149(14):12621-12635. PubMed ID: 37450030 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective. Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W Front Immunol; 2022; 13():1007426. PubMed ID: 36189217 [TBL] [Abstract][Full Text] [Related]
3. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. Wang L; Wang L; He P Front Genet; 2022; 13():1064432. PubMed ID: 36568383 [No Abstract] [Full Text] [Related]
5. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
6. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
7. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma. Li G; Xu S; Yang S; Wu C; Zhang L; Wang H Front Genet; 2022; 13():1029576. PubMed ID: 36568382 [No Abstract] [Full Text] [Related]
8. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases. Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376 [TBL] [Abstract][Full Text] [Related]
9. Effect of Tertiary Lymphoid Structures on Prognosis of Patients with Hepatocellular Carcinoma and Preliminary Exploration of Its Formation Mechanism. Li J; Nie Y; Jia W; Wu W; Song W; Li Y Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291944 [TBL] [Abstract][Full Text] [Related]
10. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes]. Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028 [No Abstract] [Full Text] [Related]
11. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma. Bai Y; Lin H; Chen J; Wu Y; Yu S Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985 [No Abstract] [Full Text] [Related]
12. A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes. Hu B; Shen X; Qin W; Zhang L; Zou T; Dong Q; Qin LX J Clin Transl Hepatol; 2022 Oct; 10(5):891-900. PubMed ID: 36304515 [TBL] [Abstract][Full Text] [Related]
13. Histopathological Diagnosis System for Gastritis Using Deep Learning Algorithm. Ba W; Wang SH; Liu CC; Wang YF; Shi HY; Song ZG Chin Med Sci J; 2021 Sep; 36(3):204-209. PubMed ID: 34666873 [TBL] [Abstract][Full Text] [Related]
14. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. Chen QF; Li W; Wu PH; Shen LJ; Huang ZL World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872 [TBL] [Abstract][Full Text] [Related]
15. Identification and Characterization of an Ageing-Associated 13-lncRNA Signature That Predicts Prognosis and Immunotherapy in Hepatocellular Carcinoma. Li F; Xue X J Oncol; 2023; 2023():4615297. PubMed ID: 36844873 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
17. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
18. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z Front Genet; 2021; 12():779554. PubMed ID: 34880908 [No Abstract] [Full Text] [Related]
20. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma. Li R; Zhao W; Liang R; Jin C; Xiong H Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972 [No Abstract] [Full Text] [Related] [Next] [New Search]